Robuta

The Clinical Index of Stable Febrile Neutropenia (CISNE) identifies febrile neutropenia patients at low risk of serious complications.

Patients with febrile neutropenia are at a high risk of contracting the coronavirus infection.

Multiple myeloma (MM) survival rates have been substantially increased thanks to novel agents that have improved survival outcomes and shown better...

Febrile Neutropenia Market growth is projected to reach USD 20.15 Billion, at a 4.99% CAGR by driving industry size, share, top company analysis, segments...

Press release - INFINITY BUSINESS INSIGHTS - Febrile Neutropenia Market Significantly Stepping towards the Success Till 2027 - published on openPR.com

Researchers have determined that febrile neutropenia has a low rate of bacteremia and approximately half of patients receive the recommended initial empiric...